These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7563337)

  • 1. A study in patients with erectile dysfunction comparing different formulations of prostaglandin E1. Alprostadil Study Group.
    Vanderschueren D; Heyrman RM; Keogh EJ; Casey RW; Weiske WH; Ogrinc FG; de Koning Gans HJ
    J Urol; 1995 Nov; 154(5):1744-7. PubMed ID: 7563337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction.
    Cawello W; Schweer H; Dietrich B; Seyberth HW; Albrecht D; Fox A; Hohmuth H
    J Urol; 1997 Oct; 158(4):1403-7. PubMed ID: 9302131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of erectile failure with prostaglandin E1: a double-blind, placebo-controlled, dose-response study.
    Godschalk MF; Chen J; Katz PG; Mulligan T
    J Urol; 1994 Jun; 151(6):1530-2. PubMed ID: 8189563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-response study of alprostadil sterile powder (S.Po.) (Caverject) for the treatment of erectile dysfunction in Korean and Indonesian men.
    Choi HK; Adimoelja A; Kim SC; Soebadi DM; Seong DH; Garceau RJ
    Int J Impot Res; 1997 Mar; 9(1):47-51. PubMed ID: 9138059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lowest effective dose of prostaglandin E1 as treatment for erectile dysfunction.
    Chen J; Godschalk M; Katz PG; Mulligan T
    J Urol; 1995 Jan; 153(1):80-1. PubMed ID: 7966797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alprostadil sterile powder formulation for intracavernous treatment of erectile dysfunction.
    Colli E; Calabrò A; Gentile V; Mirone V; Soli M
    Eur Urol; 1996; 29(1):59-62. PubMed ID: 8821692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
    Martínez-Piñeiro L; Cortés R; Cuervo E; López-Tello J; Cisneros J; Martínez-Piñeiro JA
    Eur Urol; 1998 Oct; 34(4):350-4. PubMed ID: 9748684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracavernous injection of prostaglandin E1 in spinal cord injured patients with erectile dysfunction. A preliminary report.
    Tang SF; Chu NK; Wong MK
    Paraplegia; 1995 Dec; 33(12):731-3. PubMed ID: 8927414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
    Waldhauser M; Schramek P
    J Urol; 1988 Sep; 140(3):525-7. PubMed ID: 3045341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavernous injection of prostaglandin E1 plus procaine in the treatment of erectile dysfunction.
    Schramek P; Plas EG; Hübner WA; Pflüger H
    J Urol; 1994 Oct; 152(4):1108-10. PubMed ID: 8072075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of a new formulation of prostaglandin E1 as treatment for erectile failure.
    Godschalk M; Gheorghiu D; Chen J; Katz PG; Mulligan T
    J Urol; 1996 Mar; 155(3):915-7. PubMed ID: 8583606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical prostaglandin E1 SEPA gel for the treatment of erectile dysfunction.
    McVary KT; Polepalle S; Riggi S; Pelham RW
    J Urol; 1999 Sep; 162(3 Pt 1):726-30; discussion 730-1. PubMed ID: 10458353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
    Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
    J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative value of prostaglandin E1 and papaverine in treatment of erectile failure: double-blind crossover study among Egyptian patients.
    Mahmoud KZ; el Dakhli MR; Fahmi IM; Abdel-Aziz AB
    J Urol; 1992 Mar; 147(3):623-6. PubMed ID: 1538443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkalization does not alleviate penile pain induced by intracavernous injection of prostaglandin E1.
    Godschalk M; Gheorghiu D; Katz PG; Mulligan T
    J Urol; 1996 Sep; 156(3):999-1000. PubMed ID: 8709384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].
    Schrey A
    Fortschr Med; 1990 Oct; 108(30):577-80. PubMed ID: 2245960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of alprostadil sterile powder in a home self-injection study of Asian men with erectile dysfunction.
    Wu CC; Xue ZY; Apichat K; Huang ST; He Z; Garceau RJ
    Clin Ther; 1996; 18(2):256-64. PubMed ID: 8733986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind randomized crossover study comparing intracorporeal prostaglandin E1 with combination of prostaglandin E1 and lidocaine in the treatment of organic impotence.
    Kattan S
    Urology; 1995 Jun; 45(6):1032-6. PubMed ID: 7771004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostaglandin treatment in neurological patients with erectile dysfunction].
    Conejero Sugrañes J; Muñoz Villellas A; Sarrias Lorenz F; Ramírez Garceran L
    Arch Esp Urol; 2002; 55(1):63-8. PubMed ID: 11957754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of a comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
    Martinez-Piñeiro L; Lopez-Tello J; Alonso Dorrego JM; Cisneros J; Cuervo E; Martinez-Piñeiro JA
    J Urol; 1995 May; 153(5):1487-90. PubMed ID: 7714974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.